How European Health Systems Use CPAP Telemonitoring Data to Decide If Your Treatment Stays Covered

How European Health Systems Use CPAP Telemonitoring Data to Decide If  - Back2Sleep

CPAP telemonitoring reimbursement Europe rules decide very different things in France, Belgium and Germany

The hours your machine records mean something completely different depending on which European country you live in.

What CPAP telemonitoring reimbursement Europe rules actually measure

CPAP telemonitoring reimbursement Europe rules turn on one number, and that number is total hours of use. CPAP telemonitoring means your machine records how long you wear the mask each night and, in several countries, sends that figure through a SIM card modem to a cloud platform your care team can read remotely. Before anyone else interprets your numbers, our guide to Sécurité Sociale and mutuelle coverage in France explains the reimbursement pathway they sit inside.

Everything else your device records is clinical rather than administrative. Your IAH residuel (residual AHI, the apnoea-hypopnoea index still recorded while you are on therapy), your fuites au masque (mask leak) and your pressure settings tell your clinician whether treatment is working. The hours tell a payer or a provider whether a contract continues. Confusing the two is where most of the anxiety starts.

Most English-language pages describe a rule that does not exist here. The standard of four hours a night on 70% of nights in a 30-day window, tied to a 90-day trial and a 13-month rental-to-purchase timeline, belongs to United States insurance. No European system below uses either.

97%
French CPAP patients telemonitored in 2023 (IMPACT-PAP, 2024)
78%
already at 4h a night or more at one month (IMPACT-PAP, 2024)
5.5h
mean nightly use at one year (IMPACT-PAP, 2024)
43.5%
stopped CPAP within 3 years (European Respiratory Journal, 2024)

France implemented national CPAP telemonitoring with a pay-for-performance homecare provider scheme in 2018, and by 2023 about 97% of treated patients were telemonitored, according to the IMPACT-PAP cohort study published in Archivos de Bronconeumología in 2024. That study followed 11,166 patients starting therapy in 2018-2019 and reported mean usage of 5.5 plus or minus 2.2 hours a night at one year, with 49.5% of the initially low-adherence group reaching high adherence within twelve months.

Key Takeaway
  • Telemonitoring records usage hours, residual AHI, leak and pressure, but only the hours carry administrative weight.
  • The four-hour, 70%-of-nights rule is a United States insurance rule, not a European one.
  • In France telemonitoring is near-universal in practice rather than exceptional.
Infographic about How European Health Systems Use CPAP Telemonitoring Data to

CPAP telemonitoring reimbursement Europe compared country by country

The same four-hour figure appears in several European systems, but it triggers a completely different consequence in each one. The table below is the short answer.

Country Who sees the data Measurement used What the number decides First consequence if you fall short
France Your PSAD (prestataire de santé a domicile), through the télésuivi platform Monthly hours on a 28-day moving window Your provider's forfait hebdomadaire PPC tier A phone call or a home visit from the provider
Belgium Your INAMI/RIZIV-accredited centre du sommeil agréé, at appointments 4 hours a night on average over a reference period of at least 2 months Whether your convention renews for 12 months A shortened 3-month joker renewal
Germany Normally nobody remotely; Betriebsstunden are read from the counter or reported by you Regular use, checked at defined review points Whether Folgeversorgung follows the initial Erstversorgung Questions about operating hours and therapy problems
United States (contrast only) The supplier, reporting to the insurer 4 hours on 70% of nights in a 30-day window Whether the insurer keeps paying at all Loss of coverage and a restarted trial period
Key Takeaway
  • France uses the number to pay a company, Belgium to renew a contract, Germany largely does not collect it remotely.
  • Only the United States model removes a machine over usage hours alone.
  • Identify which system you are in before you worry about one difficult week.
Back2Sleep nasal stent simple drug-free option

France pays your provider on the number, not you

In France your observance PPC figure sets how much the Assurance Maladie pays your homecare provider, not what you personally receive. French paperwork calls the condition SAHOS, the syndrome d'apnées-hypopnées obstructives du sommeil, and calls the therapy PPC rather than CPAP. The forfait hebdomadaire is provider revenue listed on the LPPR, the liste des produits et prestations remboursables. A major French PSAD states this plainly on its own patient pages: home care for sleep apnoea is reimbursed under identical conditions for the patient, whether that person is telemonitored or not, and whether they are observant or not.

The tiers below come from the LPPR tariff schedule as reported by the French health insurer APRIL for 2025-2026. Read them as your provider's income, not as your bill.

LPPR situation Monthly telemonitored use Weekly forfait (2025) Paid to
Initial phase (max 13 weeks) Any 16.63 EUR PSAD
9.TL1 More than 112 hours 14.80 EUR PSAD
9.TL2 56 to 112 hours 9.25 EUR PSAD
9.TL3 Under 56 hours 3.80 EUR PSAD
Non-télésuivi (9.NT codes), partial observance Not transmitted 7.79 EUR PSAD
Non-télésuivi (9.NT codes), rigorous observance Not transmitted 11.69 EUR PSAD

From April 2026 the top tier falls to 14.21 EUR and the lowest to 3.65 EUR, while the non-télésuivi rates move to 7.10 EUR and 10.66 EUR, on the same APRIL 2025-2026 schedule. A separate code, 9.SRO, covers patients with no observance record at all. France also leads Europe on remote patient monitoring reimbursement, where the LATM replaced the previous national programme in July 2023, a Ministry of Health decree of 20 May 2026 sets three annual tariff cuts of 10% for older telemonitoring activities, and HAS opened a re-evaluation of PPC devices in March 2025.

Why the old three-hour rule has no force against you

The Conseil d'Etat annulled observance-conditioned CPAP reimbursement on 28 November 2014, striking down the ministerial orders of 9 January and 22 October 2013 that had demanded a minimum of three hours per 24-hour period on at least 20 days, verified by automatic remote data transmission. The Cour de cassation confirmed the position on 18 June 2015, holding that in the absence of any text sanctioning non-use, continued coverage of respiratory assistance could not be refused.

Two administrative details still matter. A demande d'accord préalable (DAP) is mandatory for every patient aged 16 or over treated by PPC or by an orthèse d'avancée mandibulaire (OAM). If the CPAM does not answer within 15 days the agreement is implicit, and dematerialised submission became obligatory from 31 December 2024. The calculation runs on 28-day moving windows rather than calendar months, so the count rolls forward continuously instead of resetting on the first of the month. If your file is recognised as an ALD (affection de longue durée), related care is exonerated at 100%, and a mutuelle complementaire santé covers what remains.

Key Takeaway
  • Télésuivi PPC tiers are your PSAD's revenue under the LPPR, not a penalty applied to you.
  • Court rulings in 2014 and 2015 removed the legal basis for cutting a patient's coverage over usage hours.
  • On a 28-day moving window, a difficult week keeps rolling out of the calculation.
Choose Your Size →

Belgium runs a convention, an average and one joker

In Belgium CPAP is not bought but supplied on loan, in bruikleen, by an INAMI/RIZIV-accredited sleep centre, and the machine stays the centre's property. Adult eligibility uses the IAHO, the indice d'apnées-hypopnées obstructives, a Belgian index that counts obstructive events only, at 15 per hour or more.

The convention requires four hours a night on average across the whole reference period, which runs for a minimum of two months. An average forgives single nights. A first agreement lasts three months, and standard renewals then run twelve months at a time. Patient copayment is about 0.25 EUR a day, roughly 7 to 8 EUR a month, and zero for BIM (intervention majoree) beneficiaries.

If the average falls short, the centre can issue a shortened three-month renewal, widely known as the joker. Failing that joker triggers a full one-year suspension of the convention, a far harsher outcome than the United States framing that dominates search results. Your usage record is reviewed by the accredited sleep centre at the renewal appointment, so ask to see the figure and have it explained rather than waiting for a verdict.

Note Belgian adherence is strong by international standards. Three-month CPAP compliance has been reported at 88% in Belgium versus 69% in the United States, in a 2022 review of telemonitoring for the follow-up of OSA patients treated with CPAP, indexed on PubMed Central as PMC9002933.
Key Takeaway
  • The Belgian threshold is a four-hour average over at least two months, not a per-night test.
  • A compliance problem shortens your renewal to three months rather than ending cover immediately.
  • Failing the joker means a year of ineligibility, so raise problems early with your centre.
Innovation in sleep apnea treatment

Germany does not read your machine remotely

In Germany no automatic remote reading of your device by the Krankenkasse or the Versorger takes place. Usage is documented as Betriebsstunden, the operating hours either read off the device counter or requested from you. CPAP is supplied as a Hilfsmittel listed in the Hilfsmittelverzeichnis, and Kostenübernahme is granted for a defined period rather than indefinitely.

One large statutory insurer, DAK, schedules an assessment of operating hours and therapy problems after ten months have elapsed, and states that Folgeversorgung is covered where the device is used regularly. Another company health fund approves the initial supply for six months, during which therapeutic success is checked. German paperwork calls the proof of use a Compliance-Nachweis, and the underlying concept is Therapieadharenz. The Medizinischer Dienst (MDK) is the review service statutory funds consult for an independent opinion.

German data protection adds a national layer on top of EU rules. Telemonitoring sits under the TTDSG, in force since December 2021, alongside the Digitale-Versorgung-Gesetz and the Gesundheitsdatenschutzgesetz. The German sleep medicine society position on telemonitoring in sleep-disordered breathing holds that patients must be able to decline telemonitoring without disadvantage, for example without being pushed onto outdated devices. Long-term adherence also differs widely by country: a 2025 multicentre retrospective study indexed on PubMed Central (PMC12459958) reports 63% at 13 months in Germany, 68% at 60 months in the UK and 55% at 60 months in Switzerland. Our step-by-step Krankenkasse coverage guide sets out the full pathway.

Key Takeaway
  • Nobody in the German system watches your nightly hours by default.
  • Operating hours are checked at defined review points, typically before Folgeversorgung is approved.
  • Declining telemonitoring should not disadvantage the care you receive.

What actually happens first when your usage drops

In France the first event is a contact from your homecare provider, not a letter from the payer. The IMPACT-PAP cohort study, published in 2024 and indexed on PubMed under PMID 39004531, measured a mean of 7.65 plus or minus 4.3 provider interactions in year one for low-adherence patients, against 5.4 plus or minus 3.4 for high-adherence patients.

1Expect a call, and use it well

Having three to four provider interactions was associated with better one-year adherence (OR 1.24, 95% CI 1.05-1.46) in that same 2024 IMPACT-PAP analysis, while more than seven interactions was associated with worse one-year adherence.

2Fix the mask before the numbers

In the first six months of therapy 38% of patients require a mask change and 7.5% a pressure modification, in the 2022 PubMed Central review of telemonitoring follow-up (PMC9002933). Report leak and comfort problems early.

3Ask for the actual figure

Request your monthly hours, residual AHI and leak values in writing. If you can read them yourself, you can question an inaccurate summary before it reaches a renewal decision.

4Treat a bad month as clinical, not moral

Insomnia, nasal congestion, pressure intolerance and mask fit are practical problems with practical answers. Our list of practical ways to stick with CPAP therapy covers the fixes that move hours most.

Important Using a nasal device such as Back2Sleep on a night you skip your mask does not register as CPAP usage hours, so it will make your telemonitoring figure worse, not better. Back2Sleep is a CE-certified soft silicone nasal stent for snoring and mild-to-moderate obstructive sleep apnoea, and it is not a substitute for prescribed CPAP therapy.
Key Takeaway
  • A drop in hours triggers support before it triggers any administrative step.
  • Mask leak and pressure tolerance are among the most commonly adjusted causes of falling usage.
  • No alternative device counts toward your CPAP adherence record.
Try Back2Sleep Tonight →

CPAP telemonitoring reimbursement Europe and your data rights

Under GDPR you hold rights of access, data portability, erasure and objection over your CPAP data. The practical catch is that the controller is usually your homecare provider or the manufacturer's cloud platform rather than the payer, so a request for your record goes to them. In France télésuivi is set up only with a free, informed, explicit and documented signed consent, so it can be declined, and consent given freely can be withdrawn. You then move to the non-télésuivi LPPR codes, and your own reimbursement conditions stay unchanged.

Data ownership across Europe is genuinely unsettled. The European Respiratory Society statement on advanced telemedicine for obstructive sleep apnoea, known as e-Sleep and published in the European Respiratory Journal in 2025, names legal, technological and ethical questions around data ownership and curation as a significant hurdle to safe implementation, and notes that the best telemedicine model differs by country because reimbursement policies differ.

Stopping is common, and it is not a permanent verdict. A French nationwide analysis of 344,969 CPAP patients published in the European Respiratory Journal in 2024 found 150,111 patients (43.5%) had a first CPAP termination within three years of starting, and 27,212 of those (26%) resumed within the following year. In that analysis, resumption followed by continuation was associated with lower all-cause mortality than resumption followed by a second termination.

If CPAP genuinely is not working for you

Speak to your sleep centre about reimbursed alternatives first. A mandibular advancement device, the orthèse d'avancée mandibulaire, is reimbursed in France and is now a statutory benefit in Germany for suitable patients. A repeat polysomnography (PSG, a full overnight sleep study) or a fresh titration may change your category, since eligibility thresholds sit at an apnea-hypopnea index of 15 or 30 depending on the country and your symptoms. If a repeat study places you in the mild range or leaves residual snoring, self-funded options become reasonable, including nasal stents, which are not reimbursed by any statutory scheme in France, Germany, Belgium or the Netherlands. Restarting reimbursed therapy is arranged through your prescriber or sleep centre, and in France a fresh demande d'accord préalable is required.

Key Takeaway
  • Ask your provider or the cloud platform, not your insurer, for a copy of your data.
  • Consent to télésuivi is withdrawable and does not change your own coverage terms.
  • Stopping is common and reversible, and continuing after a restart is what the outcome data favours.
Infographic about How European Health Systems Use CPAP Telemonitoring Data to

What Back2Sleep Users Say

★★★★☆
"Smart design but with some reservations. Once in place, this flexible segmented tube effectively restores normal ventilation. However, it won't work if your nostrils are chronically congested (allergies, etc). The lower end of the tube can also get blocked by secretions. At 35 euros per month for 2 tubes, you'd expect premium results. Still evaluating."
— Michel Verified Amazon Purchase
★★★★★
"I tried several devices — nasal dilators, mandibular advancement splints, jaw blockers. After my first night with Back2Sleep, the effect was spectacular. I didn't snore at all, which is exceptional for me. I felt like I finally breathed through my nose properly. I'm currently using a CPAP machine, and I can say Back2Sleep is more effective. The slight discomfort in the throat goes away after a few nights. I highly recommend this device."
— Benjamin Verified Amazon Purchase
★★★★★
"The only device that actually works against snoring. Highly recommended!"
— Yavor Verified Amazon Purchase

Frequently Asked Questions

How many hours a night do I need to use CPAP to keep it reimbursed in France?

No legal minimum applies to you personally. The Conseil d'Etat annulled observance-conditioned reimbursement on 28 November 2014 and the Cour de cassation confirmed this on 18 June 2015. The 112-hour and 56-hour monthly thresholds still exist, but they set your homecare provider's weekly forfait, not your own Assurance Maladie coverage.

Can my insurance stop paying for my CPAP if I do not use it enough?

Not in France, where court rulings in 2014 and 2015 removed the legal basis for conditioning your reimbursement on usage hours. In Belgium low average use can shorten your INAMI convention to a three-month joker and, if that fails, suspend it for a year. In Germany regular use supports Folgeversorgung approval.

Kontrolliert die Krankenkasse die Nutzungsdauer meines CPAP-Gerats aus der Ferne?

No. German sources are consistent that no automatic remote reading by the Krankenkasse or the Versorger takes place. Usage is proven by Betriebsstunden, read from the device counter or reported by you. One large statutory insurer, DAK, schedules an assessment of operating hours and therapy problems after ten months, before Folgeversorgung is approved.

Puis-je refuser le télésuivi de ma PPC et est-ce que ca change mon remboursement ?

Yes. Télésuivi requires a free, informed, explicit and documented signed consent, so you can decline it, and freely given consent can be withdrawn. You then move to the non-télésuivi LPPR codes, or to code 9.SRO if no observance record exists at all. Your own reimbursement conditions stay identical, and only your provider's forfait changes.

Wat gebeurt er als ik minder dan 4 uur per nacht CPAP gebruik in de conventie?

Your INAMI/RIZIV convention is judged on a four-hour nightly average across a reference period of at least two months, not on single nights. A compliance problem usually triggers a three-month joker renewal instead of the standard twelve months. Failing that joker means a full one-year suspension of the convention.

Who actually sees my CPAP usage data in France, Germany or Belgium?

In France your PSAD homecare provider receives it remotely through the télésuivi platform. In Belgium your accredited sleep centre reviews it at the convention renewal appointment. In Germany normally nobody reads it remotely at all. Under GDPR the data controller is usually the provider or the manufacturer cloud platform, not your insurer.

If my CPAP coverage stops, can I get it back later?

Yes, in many cases. A French nationwide analysis published in the European Respiratory Journal in 2024 found 43.5% of 344,969 patients had a first CPAP termination within three years, and 26% of those resumed within the next year. Restarting is arranged through your prescriber or sleep centre, with a fresh demande d'accord préalable in France.

Is the American 4 hours on 70 percent of nights rule the same in Europe?

No. That rule belongs to United States insurance, alongside a 90-day trial and a 13-month rental-to-purchase timeline that no European system uses. France measures monthly hours on a 28-day moving window, Belgium uses a four-hour average over a reference period, and Germany checks operating hours at defined review points.

Medical Disclaimer: This article is for informational purposes only and does not replace professional medical advice. Snoring can be a symptom of obstructive sleep apnea, a serious medical condition. If you suspect sleep apnea, consult a healthcare professional. Back2Sleep is a CE-certified Class I medical device intended for the treatment of snoring and mild to moderate sleep apnea.

Ready for quieter nights? Discover the Back2Sleep starter kit and find the right fit for you.

Not sure if you are at risk? Take our sleep risk screening to find out in just a few minutes.

Want to learn how it works? Explore the Back2Sleep nasal stent designed for comfortable, effective relief.

Back to blog